Treatment of diabetic db/db mice with an iNOS inhibitor reversed hyperglycaemia and improved insulin sensitivity, showing that the down-regulation of iNOS mRNA in macrophages is the molecular target for the prevention of not only inflammation but also type-2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.